Home/ Supplements/ Vitamin C/ Corvite 150

Corvite 150

product on market Tablet or Pill Vertical Pharmaceuticals Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 78% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains B vitamins and vitamin C, which are supported by strong evidence for maintaining energy metabolism and immune function. Calcium threonate provides a source of calcium for bone health, though evidence for its specific absorption superiority is more limited. The ingredient profile is associated with a high safety score.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Corvite 150
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
30
Servings
Multi-Vitamin and Mineral (MVM)
Product Type
78%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Vitamin C
120 mg (200% DV)
5 mg (0.5% DV)
Market median: 4002.0mg (1 products) 21 studies (A:0, B:2)
10 mg (500% DV)
7.7× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
100 mcg (33% DV)
3.3× RDA — above typical dose 27 studies (A:0, B:11)
20 mcg (333% DV)
8.3× RDA — above typical dose 139 studies (A:1, B:44)
1 mg (250% DV)
2.5× RDA — within safe limits 226 studies (A:10, B:105)
Iron
150 mg (833% DV)
10 mg (3% DV)
Market median: 500.0mg (1 products) 316 studies (A:8, B:159)
25 mg (167% DV)
2.3× RDA — within safe limits 263 studies (A:6, B:134)

Other Ingredients

Microcrystalline Cellulose Starch, Pregelatinized Dicalcium Phosphate Hydroxypropylmethylcellulose Polyvinyl alcohol FD&C Red #40 Lake Polyethylene Glycol Talc Titanium Dioxide Croscarmellose Sodium Stearic Acid Magnesium Stearate
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Dosage & Administration Usual adult dose is 1 tablet daily, or as directed by a physician.

Warnings & Precautions

Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Contraindications: Corvite 150 is contraindicated in patients with a known hypersensitivity to any of the components of this product. Hemochromatosis and hemosiderosis are contraindications to iron therapy. Warnings: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin b12 is deficient. Precautions General: Do not exceed recommended dose. The type of anemia and the underlying cause or causes should be determined before starting therapy with Corvite 150. Since the anemia may be a result of a systemic disturbance, such as recurrent blood loss, the underlying cause or causes should be corrected, if possible. Folic Acid: Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. Pernicious anemia should be excluded before using this product since folic acid may mask the symptoms of pernicious anemia

Pediatric Use: Safety and effectiveness in pediatric patients have not been established.

Geriatric Use: Clinical studies on this product have not been performed in subjects aged 65 and over to determine whether elderly subjects respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious. Adverse Reactions: Adverse reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, dark stools and abdominal pain. Adverse reactions with iron therapy are usually transient.

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

Overdosage: The clinical course of acute iron overdosage can be variable. Initial symptoms may include abdominal pain, nausea, vomiting, diarrhea, tarry stools melena, hematemesis, hypotension, tachycardia, metabolic acidosis, hyperglycemia, dehydration, drowsiness, pallor, cyanosis, lassitude, seizures, shock and coma.

Keep out of the reach of children.

Call your doctor about side effects.

Formulation Notes

Now with Quatrefolic

Iron Supplementation

Sugar, lactose & gluten free

Vegan safe

Clinical Pharmacology: Iron is an essential component in the formation of hemoglobin. Adequate amounts of iron are necessary for effective erythropoiesis. Iron also serves as a cofactor of several essential enzymes, including cytochromes that are involved in electron transport. Folic acid is required for nucleoprotein synthesis and the maintenance of normal erythropoiesis. Folic acid is converted in the liver and plasma to its metabolically active form, tetrahydrofolic acid, by dihydrofolate reductase. Vitamin B12 is required for the maintenance of normal erythropoiesis, nucleoprotein and myelin synthesis, cell reproduction and normal growth. Intrinsic factor, a glycoprotein secreted by the gastric mucosa, is required for active absorption of vitamin B12 from the gastrointestinal tract.

Indications and Usage: Corvite 150 is indicated for the prevention and treatment of iron deficiency anemia and/or nutritional megaloblastic anemias.

Additional Information

68025-052-30 Rx only

Storage Store at controlled room temperature 15 degrees-30 degrees C (59 degrees-86 degrees F) [see USP]. Protect from light and moisture and avoid excessive heat. Dispense in a tight, light resistant container as defined by the USP using a child-resistant closure.

Description: Corvite 150 are red, oval bisected tablets embossed "VP052." How Supplied: Corvite 150 tablets are supplied in bottles of 30 units.

Lift here for full product information

Metadata

Product Details

UPC / SKU3 68025-052-30 6
DSLD Entry Date2021-12-18
Product TypeMulti-Vitamin and Mineral (MVM)
FormTablet or Pill
DSLD ID264174
Data Updated2026-04-11
Research

Research Evidence

371
Research Sources
54
Avg Quality
148
Meta Analysis
82
Systematic Review
71
Rct
62
Clinical Trial
2
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Other
1
Openfda Safety
A Vitamin C supplementation in pregnancy
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin C supplementation for the primary prevention of cardiovascular disease
Systematic Review The Cochrane database of systematic reviews 2017 PubMed DOI
A Vitamin C for preventing and treating the common cold
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Vitamin C for preventing and treating pneumonia
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Vitamin E supplementation in pregnancy
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin C supplementation for prevention and treatment of pneumonia
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Vitamin C supplementation for prevention and treatment of pneumonia
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Nutritional interventions for preventing and treating pressure ulcers
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Does Vitamin C Supplementation Provide a Protective Effect in Periodontal Health? A Systematic Review and Meta-Analysis
Meta Analysis International journal of molecular sciences 2024 PubMed DOI
A Circulating vitamin C concentration and risk of cancers: a Mendelian randomization study
Meta Analysis BMC medicine 2021 PubMed DOI
View all evidence for Vitamin C →
Compare

Similar Products

View all Vitamin C products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.